Track record · closed signal

Arrowhead Pharmaceuticals Inc (ARWR) — closed signal from April 17, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on July 16, 2026.

Predicted vs. what happened

ARWR price · publication thesis → realized outcomesplit-adjusted
$69.69 Published $78.05 Target $71.38 Window close $87.83 Peak
$66.00 – $68.00Entry zone — fair-value band
$69.69Published — price the day we called it
$78.05Target — the price the thesis aimed for
$87.83Peak — highest point inside the window, not a realized return
$71.38Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 19 days.

Peak price
$87.83
peak on July 6, 2026 — not a realized return
Peak gain
+26%
peak, from the publication price
Window close
$71.38
end-of-window price, context only
Days to target
19
Window
April 17, 2026 – July 16, 2026

The thesis — published April 17, 2026

Predicted growth
+12%
over the measurement window
Target price
$78.05
the price the thesis aimed for
Entry zone
$66.00 – $68.00
the fair-value band we waited for
Price at publication
$69.69
published April 17, 2026
Confidence
67%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Arrowhead is a higher-risk healthcare stock but has real reasons for interest. New plozasiran results renewed confidence in its RNA-based drug approach, and the company has enough cash to keep developing programs without urgent fundraising. The stock already bounced and few traders are active, so we prefer a pullback entry rather than chasing the current move.

Primary drivers

  • Plozasiran results boost faith in RNA-based drugs
  • Strong cash position lets development continue
  • Provides biotech exposure with event-driven upside
  • Better on a pullback while trading remains light

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.